How Are Market Dynamics And Regional Growth Patterns Influencing The NGS-Based RNA-Sequencing Global Market Report 2025 Market?
What Major Growth Indicators And Market Expansion Forecasts Define The NGS-Based RNA-Sequencing Global Market Report 2025 Market Through 2029?
The ngs-based rna-sequencing market size has grown exponentially in recent years. It will grow from $3.41 billion in 2024 to $4.2 billion in 2025 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to genomic research initiatives, reduction in sequencing costs, drug discovery and development, personalized medicine, increasing ngs adoption.
The ngs-based rna-sequencing market size is expected to see exponential growth in the next few years. It will grow to $10.26 billion in 2029 at a compound annual growth rate (CAGR) of 25.0%. The growth in the forecast period can be attributed to clinical diagnostics, global collaborations, ethical and regulatory frameworks, agricultural and environmental research, green genomics. Major trends in the forecast period include single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, sustainable agriculture.
Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp
Which Drivers Are Playing A Pivotal Role In Shaping The NGS-Based RNA-Sequencing Global Market Report 2025 Market’s Growth Outlook?
The growth in precision medicine is driving the NGS-based RNA sequencing market. Precision medicine aids doctors in designing individualized treatment plans and making treatment decisions based on a genetic understanding of the patient’s disease. There is a growth in precision medicines for treating severe diseases such as cancer. The NGS-based RNA sequencing helps identify the root cause of disease and prescribe specific precision medicine for treatment. For instance, in February 2023, according to a report by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, personalized medicines accounted for 35% of newly approved NMEs in 2021, and with 12 new approvals in 2022, they have maintained a consistent share of at least a quarter of new drug approvals over the past eight years, reflecting a significant increase from under 10% a decade ago. As the demand for precision medicines increases, the demand for NGS-based RNA sequencing will also increase.
How Is The NGS-Based RNA-Sequencing Global Market Report 2025 Market Broken Down Based On Its Critical Segment Classifications?
The ngs-based rna-sequencingmarket covered in this report is segmented —
1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics
4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users
Subsegments:
1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables
3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms
What New Trends Are Beginning To Take Shape Within The NGS-Based RNA-Sequencing Global Market Report 2025 Market?
Strategic Partnership is a key trend in the NGS-based RNA sequencing market. Companies are entering into a partnership with NGS-based RNA sequencing companies to expand in new markets and leverage each other’s resources. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA), a U.S. Department of Health and Human Services, partnered with multiple industry and academic partners. The partnership aims to improve the capacity to swiftly respond to public health emergencies and develop a novel diagnostic capability that covers all recognized and emerging respiratory RNA viruses in a single test.
Which Firms Hold A Significant Competitive Position In The NGS-Based RNA-Sequencing Global Market Report 2025 Market?
Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.
Get Your In-Depth NGS-Based RNA-Sequencing Global Market Report 2025 Market Report Now:
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Which Locations Are Showing Rapid Adoption And Strong Growth Indicators In The NGS-Based RNA-Sequencing Global Market Report 2025 Market?
North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment